ARIAD Pharma (ARIA) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $23.99 --0%
Financial Fact:
Interest expense: -8.42M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Interest expense: -8.42M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
ARIAD Pharma (NASDAQ: ARIA) reported Q3 EPS of ($0.27), $0.03 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $14.7 million versus the consensus estimate of $16.5 million.
For earnings history and earnings-related data on ARIAD Pharma (ARIA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
- Customers Bancorp (CUBI) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
